Lodz, Poland

Krzysztof Matyszewski

This inventor holds 7 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Molecure S.a., Oncoarendi Therapeutics S.a., Oncoarendi Therapeutics Sp. Z O.o.. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Krzysztof Matyszewski. Retrieved from https://idiyas.com/inventor/krzysztof-matyszewski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 10.8

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Krzysztof Matyszewski: Innovator in Therapeutic Compounds

Introduction

Krzysztof Matyszewski is a notable inventor based in Lodz, Poland. He has made significant contributions to the field of therapeutic compounds, holding a total of 7 patents. His work focuses on developing innovative solutions for various medical conditions.

Latest Patents

Among his latest patents are the "Deubiquitinase inhibitors and methods of use thereof." This invention involves small molecule therapeutics that serve as potent inhibitors of USP7 activity. The patent also includes pharmaceutical compositions comprising these compounds and methods for their use in treating or preventing diseases associated with USP7 activity. Another significant patent is for "YKL-40 inhibitors and their therapeutic applications." This patent discloses assays for screening active compounds that interfere with the interaction between chitinase-like protein YKL-40 and chitin oligomers, as well as with heparan sulfate. The patent further identifies active compounds as inhibitors of YKL-40 and outlines their therapeutic applications.

Career Highlights

Krzysztof has worked with several companies, including Oncoarendi Therapeutics S.A. and Molecure S.A. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

He has collaborated with notable individuals in his field, including Adam A. Golebiowski and Jacek P. Olczak. These collaborations have likely enhanced his research and development efforts.

Conclusion

Krzysztof Matyszewski is a prominent inventor whose work in therapeutic compounds has the potential to impact medical treatments significantly. His innovative patents and collaborations reflect his dedication to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…